The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPS

Last updated: February 14, 2023
Sponsor: First Affiliated Hospital of Zhejiang University
Overall Status: Active - Enrolling

Phase

N/A

Condition

Vascular Diseases

Stress

Williams Syndrome

Treatment

N/A

Clinical Study ID

NCT04421118
HEPIC2002
  • Ages 18-75
  • All Genders

Study Summary

The precise planning of TIPS, especially individual selection of stent diameter, is a hot and difficult topic in the field. We have successfully developed a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient based on three-dimensional modeling and fluid dynamics simulation. We propose the concept of virtual stent-based portal pressure gradient for the first time. With invasive pressure as reference, the accuracy of virtual stent-based portal pressure gradient will be evaluated in levels of animal experiments and clinical trials. The predictive value of virtual stent-based portal pressure gradient for individualized selection of TIPS stent diameter will be further assessed.

Eligibility Criteria

Inclusion

Criteria: Inclusion Criteria:

  • age 18-75 years;
  • high-risk treatment failure (e.g.Child-Pugh C or B grade with variceal bleeding);
  • conventional drugs and endoscopic treatment of esophageal variceal bleeding are notgood;
  • End-stage liver disease with variceal bleeding before liver transplantation;
  • successful implementation of TIPS;
  • good compliance with the requirements formulated by the study;
  • with written informed consent.

Exclusion

Exclusion Criteria:

  • Liver transplantation in the past or planning liver transplantation in the 6 months;
  • Common TIPS contraindications (e.g.NYHA level 2 of congestive heart failure ,historyof pulmonary hypertension, portal vein trunk thrombosis, multiple liver cysts,orintrahepatic bile duct dilatation);
  • severe liver dysfunction: prothrombin activity <40% or bilirubin> 50μmol / L orChild-Pugh score> 12;
  • history of hepatic encephalopathy;
  • serum creatinine> 133μmol / L;
  • severe hyponatremia (blood sodium <125mmol / L);
  • uncontrollable infections;
  • allergic to intravenous contrast agent;
  • subject refused to participate in the trial or without the ability to participate ininformed consent;
  • previous history of TIPS treatment;
  • any comorbidities or conditions that affect the test results as judged by theinvestigator.

Study Design

Total Participants: 60
Study Start date:
June 11, 2021
Estimated Completion Date:
December 20, 2024

Study Description

Transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for portal hypertension related variceal bleeding. The precise planning of TIPS, especially individual selection of stent diameter, is a hot and difficult topic in the field. A stent with smaller diameter cannot effectively reduce portal pressure, and a stent with larger diameter might cause hepatic encephalopathy resulted from excessive blood shunt. Therefore, individualized selection of TIPS stent diameter closely correlates with intervention effect and clinical outcomes. In our previous study, we have successfully developed a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient based on three-dimensional modeling and fluid dynamics simulation. In this project, we propose the concept of virtual stent-based portal pressure gradient for the first time. Accurate three-dimensional models of hepatic-portal vein system with stents of different diameters will be reconstructed using imaging control and modeling software. In addition, a standard procedure of fluid dynamics simulation will be fixed with the platform of finite element calculation. With invasive pressure as reference, the accuracy of virtual stent-based portal pressure gradient will be evaluated in levels of animal experiments and clinical trials. Lastly, the predictive value of virtual stent-based portal pressure gradient for individualized selection of TIPS stent diameter will be further assessed.

Connect with a study center

  • First Affiliated Hospital of Zhejiang University

    Hangzhou,
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.